Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

H Oettle, S Post, P Neuhaus, K Gellert, J Langrehr… - Jama, 2007 - jamanetwork.com
ContextThe role of adjuvant therapy in resectable pancreatic cancer is still uncertain, and no
recommended standard exists. ObjectiveTo test the hypothesis that adjuvant chemotherapy …

[PDF][PDF] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

H Oettle, S Post, P Neuhaus - JAMA, 2007 - old.pto.med.pl
Cel. Ocena hipotezy, że uzupełniająca chemioterapia z zastosowaniem gemcytabiny
wydłuża czas wolny od nowotworu przynajmniej o 6 miesięcy u chorych po doszczętnym …

[PDF][PDF] Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

H Oettle, S Post, P Neuhaus, K Gellert, J Langrehr… - JAMA, 2007 - krupp-krankenhaus.de
Objective To test the hypothesis that adjuvant chemotherapy with gemcitabine administered
after complete resection of pancreatic cancer improves disease-free survival by 6 months or …

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

H Oettle, S Post, P Neuhaus, K Gellert, J Langrehr… - JAMA, 2007 - europepmc.org
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent
resection of pancreatic cancer: a randomized controlled trial. - Abstract - Europe PMC Sign in …

[PDF][PDF] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

H Oettle, S Post, P Neuhaus - JAMA, 2007 - core.ac.uk
Cel. Ocena hipotezy, że uzupełniająca chemioterapia z zastosowaniem gemcytabiny
wydłuża czas wolny od nowotworu przynajmniej o 6 miesięcy u chorych po doszczętnym …

[PDF][PDF] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

H Oettle, S Post, P Neuhaus - JAMA, 2007 - journals.viamedica.pl
Cel. Ocena hipotezy, że uzupełniająca chemioterapia z zastosowaniem gemcytabiny
wydłuża czas wolny od nowotworu przynajmniej o 6 miesięcy u chorych po doszczętnym …

[PDF][PDF] Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

H Oettle, S Post, P Neuhaus, K Gellert, J Langrehr… - JAMA, 2007 - researchgate.net
Objective To test the hypothesis that adjuvant chemotherapy with gemcitabine administered
after complete resection of pancreatic cancer improves disease-free survival by 6 months or …

[引用][C] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial

H OETTLE, S POST, K GUTBERLET… - JAMA, the journal of …, 2007 - pascal-francis.inist.fr
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent
resection of pancreatic cancer : A randomized controlled trial CNRS Inist Pascal-Francis CNRS …

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer.

H Oettle, S Post, P Neuhaus, K Gellert… - JAMA: Journal of …, 2007 - search.ebscohost.com
This article presents research data comparing treatments of pancreatic cancer. The
controlled trial was an attempt to test the hypothesis that adjuvant chemotherapy with …

[引用][C] Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer

H OETTLE - JAMA, 2007 - cir.nii.ac.jp
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent
resection of pancreatic cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …